home / stock / hook / hook news

HOOK News and Press, HOOKIPA Pharma Inc.

Stock Information
Company Name: HOOKIPA Pharma Inc.
Stock Symbol: HOOK
Market: NYSE
Website: hookipapharma.com
Menu
HOOK HOOK Quote HOOK Short HOOK News HOOK Articles HOOK Message Board
Get HOOK Alerts

News, Short Squeeze, Breakout and More Instantly...
HOOK - HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting

Company will present promising preliminary progression-free survival and overall survival data for patients with combined positive score (CPS) ≥20 Conference call on Tuesday, June 4, at 4:15 p.m. ET NEW YORK and VIENNA, May 30, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc....
HOOK - HOOKIPA stock falls 20% in wake of Phase 1/2 study results

2024-05-24 14:26:46 ET More on HOOKIPA Pharma Hookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive Catalysts Hookipa to receive $10M from Roche as FDA clears cancer trial Seeking Alpha’s Quant Rating on HOOKIPA Pharma Historical earn...

HOOK - LIDR, HOOK and BCAB among mid-day movers

2024-05-24 12:58:09 ET More on BioAtla, HOOKIPA Pharma, etc. BioAtla, Inc. (BCAB) Q1 2024 Earnings Call Transcript AEye, Inc. (LIDR) Q1 2024 Earnings Call Transcript BioAtla: A Buried ADC Concern Gets Some New Life In 2024 AEye Q1 2024 Earnings Preview ...

HOOK - HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting

HOOKIPA to present an oral abstract at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting on June 4 Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile and promising clinical activity In a subset of patients with PD-L1 combined posit...
HOOK - Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch

2024-05-16 14:27:26 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks to buy understandably offer many enticing attributes, not least of which is the potential for tremendous returns. Of course, the emphasis is on the word “potential. ...

HOOK - HOOK Stock Earnings: HOOKIPA Pharma Beats EPS, Beats Revenue for Q1 2024

2024-05-09 11:55:05 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips HOOKIPA Pharma (NASDAQ: HOOK ) just reported results for the first quarter of 2024. HOOKIPA Pharma reported earnings per share of 11 cents. This was above the analyst esti...

HOOK - HOOKIPA Pharma GAAP EPS of $0.11

2024-05-09 07:57:23 ET More on HOOKIPA Pharma Hookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive Catalysts Hookipa to receive $10M from Roche as FDA clears cancer trial Seeking Alpha’s Quant Rating on HOOKIPA Pharma Historical earn...
HOOK - HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligns with U.S. Food and Drug Administration (FDA) feedback HB-200 program received Priority Medicines (PRIME) de...

HOOK - Expected US Company Earnings on Thursday, May 9th, 2024

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

HOOK - HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab

Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback HB-200 accepted for oral abstract presentation at ASCO 2024 Annual Meeting with data from...
Next 10